We are live on ! Find out more
QCG

Quadrant Capital Group Portfolio holdings

AUM $3.34B
1-Year Est. Return 29.16%
This Fund
S&P 500
This Quarter Est. Return
+4.25%
1 Year Est. Return
+29.16%
3 Year Est. Return
+77.72%
5 Year Est. Return
+92.59%
10 Year Est. Return
+303.92%
AUM
$3.31B
AUM Growth
+$234M
Cap. Flow
+$153M
Cap. Flow %
4.61%
Top 10 Hldgs %
29.6%
Holding
2,810
New
136
Increased
1,119
Reduced
861
Closed
104

Top Sells

Rank Stock Value
1
RDY icon
Dr. Reddy's Laboratories
RDY
+$3.19M
2
HD icon
Home Depot
HD
+$2.88M
3
COOP
Mr. Cooper
COOP
+$2.26M
4
PG icon
Procter & Gamble
PG
+$2.02M
5
CRM icon
Salesforce
CRM
+$1.9M

Sector Composition

Rank Sector Weight
1 Technology 22.8%
2 Financials 12.6%
3 Consumer Discretionary 7.91%
4 Healthcare 7.45%
5 Industrials 7.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYE icon
2401
Myers Industries
MYE
$1.23B
$4.53K ﹤0.01%
242
RUSHA icon
2402
Rush Enterprises Class A
RUSHA
$5.98B
$4.48K ﹤0.01%
83
QURE icon
2403
uniQure
QURE
$2.63B
$4.47K ﹤0.01%
187
CLVT icon
2404
Clarivate
CLVT
$1.36B
$4.47K ﹤0.01%
1,339
+743
+125% +$2.64K
AKO.B icon
2405
Embotelladora Andina Series B
AKO.B
$4.65B
$4.44K ﹤0.01%
159
-240
-60% -$6.25K
FAF icon
2406
First American
FAF
$7.79B
$4.42K ﹤0.01%
72
CADE
2407
DELISTED
Cadence Bank
CADE
$4.41K ﹤0.01%
103
-56
-35% -$2.22K
BSBR icon
2408
Santander
BSBR
$40.7B
$4.41K ﹤0.01%
721
GDEN
2409
DELISTED
Golden Entertainment
GDEN
$4.38K ﹤0.01%
161
+64
+66% +$1.66K
CLDX icon
2410
Celldex Therapeutics
CLDX
$2.8B
$4.35K ﹤0.01%
160
PFBC icon
2411
Preferred Bank
PFBC
$1.23B
$4.34K ﹤0.01%
46
BMBL icon
2412
Bumble
BMBL
$386M
$4.17K ﹤0.01%
1,167
LB
2413
LandBridge Co
LB
$2.1B
$4.17K ﹤0.01%
+85
New +$4.94K
SPRY icon
2414
ARS Pharmaceuticals
SPRY
$572M
$4.04K ﹤0.01%
347
PENN icon
2415
PENN Entertainment
PENN
$2.83B
$4.04K ﹤0.01%
274
-405
-60% -$6.32K
CENT icon
2416
Central Garden & Pet Co
CENT
$2.71B
$4.02K ﹤0.01%
125
-157
-56% -$5.01K
HOUS
2417
DELISTED
Anywhere Real Estate
HOUS
$3.96K ﹤0.01%
280
+164
+141% +$2.01K
SIBN icon
2418
SI-BONE Inc
SIBN
$756M
$3.96K ﹤0.01%
201
+112
+126% +$1.95K
MXL icon
2419
MaxLinear
MXL
$5.88B
$3.89K ﹤0.01%
223
ALKT icon
2420
Alkami Technology
ALKT
$1.9B
$3.88K ﹤0.01%
168
-222
-57% -$4.9K
FWRD icon
2421
Forward Air
FWRD
$466M
$3.88K ﹤0.01%
155
-68
-30% -$1.53K
REPL icon
2422
Replimune Group
REPL
$724M
$3.81K ﹤0.01%
392
+327
+503% +$2.78K
GH icon
2423
Guardant Health
GH
$19.3B
$3.78K ﹤0.01%
37
EVO icon
2424
Evotec
EVO
$682M
$3.78K ﹤0.01%
1,226
-3,624
-75% -$12.4K
HPK icon
2425
HighPeak Energy
HPK
$855M
$3.75K ﹤0.01%
+790
New +$4.75K

Similar funds

Quadrant Capital Group's Q4 2025 Portfolio in Review

As of Q4 2025, Quadrant Capital Group held 2,810 positions worth $3.31B, up 7.6% from $3.08B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Quadrant Capital Group deployed $153M of net new capital in Q4 2025, opening 136 new positions and adding to 1,119 existing holdings. Its largest new stake was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Dr. Reddy's Laboratories, an estimated $3.19M trimmed.

  • Quadrant Capital Group's largest Q4 2025 buy was Capital Group Global Growth Equity ETF: 18,866 shares worth $654K.
  • Quadrant Capital Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $16.7M increase.
  • Quadrant Capital Group's biggest Q4 2025 reduction was Dr. Reddy's Laboratories, cutting an estimated $3.19M.
  • Quadrant Capital Group fully exited Mr. Cooper in Q4 2025, selling an estimated $2.26M.
  • Quadrant Capital Group's ten largest holdings make up 30% of its $3.31B portfolio in Q4 2025.
  • Quadrant Capital Group opened 136 new positions and closed 104 in Q4 2025.
  • Quadrant Capital Group's portfolio value rose 7.6% quarter-over-quarter to $3.31B.

Based on Quadrant Capital Group's 13F filing for Q4 2025, filed 13 Feb 2026.